-
Non-abandonable 0.005%. Natural Research Rare Cancer Research Album
Time of Update: 2020-12-25
to test new treatments for rare cancers, it often takes longer to recruit a sufficient number of patients to participate in clinical trials.
research is a brand owned by Springer Nature Group, the world's leading scientific research, education and professional publishing organization.
-
Globally, there are more than 30 million new crown confirmed cases
Time of Update: 2020-12-05
17 (Xinhua) -- As of 18:22 ET (6:22 p.m. Beijing time) on the 17th, the cumulative number of confirmed cases of new crowns worldwide exceeded 30 million, reaching 30003378 cases and 943,203 deaths, according to the latest statistics released by Johns Hopkins University on The 17th.
-
Strategies for Resistance Management
Time of Update: 2020-11-20
Subsequent laboratory experiments have selected resistance in several other species ( 7 ).
-
Garcos Pharmaceuticals SHP2 inhibitors are eligible for FDA orphan drugs
Time of Update: 2020-11-07
it's worth noting that in June, Garcos Pharmaceuticals and AbbVie announced a global strategic partnership to jointly develop and commercialize SHP2 inhibitors that act on key targets for cancer cells and immune cells.
-
Noshingjian Obutini has been approved by the FDA to conduct a phase II study on the treatment of MS
Time of Update: 2020-11-04
MS is an autoimmune central nervous system disease in which the patient's immune system abnormally attacks the myelin around nerve cells, causing inflammation and tissue damage that disrupts the normal functioning of the brain, optic nerve and spinal cord.
-
Detection of immobilized yeast cells and sucrase
Time of Update: 2020-10-27
2. To master the detection method of sucrose enzyme vitality.
II, experimental principle solid phase enzyme, also known as fixed enzyme, is a combination of water-soluble enzyme and solid water insoluble support (or carrier) through physical and chemical treatment methods.
-
Take stock. The latest global list of approved medicines and devices in September 2020
Time of Update: 2020-10-19
fda completed a total of 90 drug first approvals (without provisional approval); approved 1 PMA device for the first time in September, affected by the materials needed for domestic and foreign outbreaks, medical device approval this month is still concentrated in injection, nursing and protective equipment, this month a total of 552 approved, accounting for 35.7%.
-
Scientists' new achievements in cancer recurrence research
Time of Update: 2020-10-14
Doi:10.1038/s41590-020-0733-2 In a recent study published in the international journal Nature Immunology, scientists from the University of Pittsburgh and other institutions found that by blocking "immune memory checkpoints" identified in immune cells, or improving immunotherapy and helping to prevent cancer recurrence.
-
Gilead Kite vice president leaves, Bayer CEO term extended
Time of Update: 2020-10-03
Peter Emage's role will now be temporarily taken over by Ken Takeshita, Senior Vice President and Global Head of Clinical Development at Kite, and the company will continue to seek a new successor, according to people familiar with the matter.
-
The United States has developed artificial intelligence robots to pick tomatoes
Time of Update: 2020-09-15
start-up has developed a robot that can automatically identify fruit ripening using artificial intelligence and pick tomatoes expertly and .
, a Massachusetts-based company called Root AI, has developed the first artificial intelligence robot for agriculture, Virgo 1.
-
Better than Xalkori! Beida Pharmaceuticals ALK inhibitor NSCLC Phase III clinical reached the main endpoint
Time of Update: 2020-08-12
results showed that the median progression-free survival (mPFS) in patients treated with Ensatinib for ALK-positive non-small cell lung cancer (NSCLC) was significantly longer than in patients treated with cratinib and reached the primary endpoint.
-
Huahai Pharmaceuticals hydrochloride sheet was approved by the U.S. FDA
Time of Update: 2020-07-30
this acetate tablet salinate has been approved by the U.S. FDA, marking Huahai Pharmaceuticals has the qualifications to sell the product in the U.S. market.
announcement also revealed that, so far, Huahai Pharmaceuticals has invested about 8.4 million yuan in research and development costs in the hydrochloric acid methyl ester sheet project.
-
China has adjusted tariffs on about $75 billion in imports originating in the United States
Time of Update: 2020-07-22
On February 6, , the State Council's Committee on Tariffs and Tariffs issued a notice to adjust tariff measures for some imports originating in the United States in order to promote the healthy and
-
New breakthrough in protein degradation: Tsinghua Chen's team has developed proTAC peptides targeting beta-catenin for the first time, effectively suppressing colon cancer
Time of Update: 2020-07-20
It can not only inhibit Wnt signal at the cell level, but also play a good role in a variety of mouse tumor models Tumor suppressor effect, more importantly, can also play an important role in tumor like organs of patients with colon cancer.
-
Study shows congenital infertility may be passed on to the next generation
Time of Update: 2020-07-04
a new study by researchers in Denmark and the United States that in vitro fertilization may pass on congenital infertility to the next generation of , lead to more infertility in the next generat
